Senior insider sale
SVP, Finance and Treasurer at ORUKA THERAPEUTICS, INC. — senior position signals high conviction
$3.90M
50.32K shares
What this filing means
AGARWAL ARJUN plans to sell 50.32K shares of ORUKA THERAPEUTICS, INC. valued at approximately $3.90M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/13/2026ACC: 0001950047-26-007037
Officer· SVP, Finance and Treasurer
Since Aug 2024
50.32K
Shares to sell
$3.90M
Approx. market value
28.59K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
7/13/2026
28.59KTotal acquired28.59K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/13/2026 | Exercise of Stock Options Cash | 28.59K | — |
| Total | 28.59K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
1.59K
Market value
$128.5K
6/22/2026
—Completed
Units to sell
395.00
Market value
$27.5K
6/15/2026
—Completed
Units to sell
9.46K
Market value
$659.5K
6/12/2026
—Completed
Units to sell
10.29K
Market value
$607.8K
5/18/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
28.59K
Market value
$2.48M
7/13/2026
Total
Units
50.32K
Value
$3.90M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/22/2026 | 1.59K | $128.5K | — | Completed |
6/15/2026 | 395.00 | $27.5K | — | Completed |
6/12/2026 | 9.46K | $659.5K | — | Completed |
5/18/2026 | 10.29K | $607.8K | — | Completed |
| Planned — Approximate Date | ||||
7/13/2026 | 28.59K | $2.48M | NASDAQ | Planned |
| Total | 50.32K | $3.90M | ||